Organization · Private Equity
The Sylvan Group
The Sylvan Group is an independent private equity investment firm based in Singapore, focusing on mid-market companies in the Asia-Pacific region. It emphasizes sustainable investments that align with the United Nations Sustainable Development Goals.
Overview
What The Sylvan Group does
What The Sylvan Group is
The Sylvan Group is an independent private equity investment firm based in Singapore, focusing on mid-market companies in the Asia-Pacific region. It emphasizes sustainable investments that align with the United Nations Sustainable Development Goals.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find The Sylvan Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
The Sylvan Group as a funder
Investment thesis
The Sylvan Group invests in mid-market companies across the Asia Pacific region, targeting upper quartile financial returns while creating meaningful social and environmental impact aligned with the UNSDGs.
Focus narrative
The Sylvan Group invests in mid-market companies across the Asia Pacific region, with a focus on achieving upper quartile financial returns while creating meaningful social and environmental impact. The firm emphasizes investments aligned with the United Nations Sustainable Development Goals (UNSDGs) and operates under three key themes: Climate and Environmental Action, Inclusive Growth, and Innovation for Sustainable Life.
Focus and fit
- Regions
- Asia
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 4
Portfolio context
The Sylvan Group's maiden fund, the Sylvan Asia Growth Fund I, has invested approximately $140 million in four Singapore-based healthcare and pharmaceutical companies, including Artemis Health Ventures, a musculoskeletal care provider, and Singapore Orthopaedic Specialists (SOS), which focuses on integrated musculoskeletal care.
Common questions
What to know about The Sylvan Group
Upseed classifies The Sylvan Group under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.